...not brought in a new small molecule drug discovery capability since 2000, when it bought Signal Pharmaceuticals Inc....

...2006 Avidia Amgen (NASDAQ:AMGN) $380 Protein engineering 2005 Idun Pfizer (NYSE:PFE) $298 Apoptosis, caspases 2000 Signal Pharmaceuticals...

...at higher doses. CELG's work on SERMs, which is derived from its 2000 acquisition of Signal Pharmaceuticals Inc....

...and Douglas Richards as VP of business development, formerly VP of business development at Signal Pharmaceuticals Inc. WIR...

...in-house anti- tumor necrosis factor (TNF) program, and a program in signal transduction pathways with Signal Pharmaceuticals Inc....

...in-house anti- tumor necrosis factor (TNF) program, and a program in signal transduction pathways with Signal Pharmaceuticals Inc....

...on CELG's Thursday close of $74.75 (see BioCentury, July 3). Celgene Corp. (CELG), Warren, N.J. Signal Pharmaceuticals Inc....

...than take on the risk of doing our own IPO." Last week. s takeout of Signal Pharmaceuticals Inc....

...drug and for its roots in chiral drug development. Thus the company's decision to acquire Signal Pharmaceuticals Inc....

...shares, or $195 million (see BioCentury Extra, Friday June 30). Celgene Corp. (CELG), Warren, N.J. Signal Pharmaceuticals Inc....